Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,352 | 216,893 | 82,411 | 125,987 | 97,690 |
| Marketable Securities | 88,311 | 20,744 | N/A | 0 | 0 |
| Receivables | 250,496 | 119,639 | 62,436 | 122,334 | 198,800 |
| Inventories | 2,048 | 4,513 | 3,518 | 4,207 | 47,640 |
| Other current assets | 8,700 | 11,716 | 154,902 | 82,402 | 14,176 |
| TOTAL | $460,955 | $380,205 | $310,175 | $341,583 | $369,024 |
| Non-Current Assets | |||||
| PPE Net | 1,633 | 1,907 | 2,256 | 2,576 | 2,911 |
| Intangibles | 49,484 | 52,312 | 52,979 | 53,646 | 54,313 |
| Other Non-Current Assets | 4,447 | 5,040 | 5,656 | 50,728 | 78,752 |
| TOTAL | $55,564 | $59,259 | $60,891 | $106,950 | $135,976 |
| Total Assets | $516,519 | $439,464 | $371,066 | $448,533 | $505,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,893 | 37,622 | 40,930 | 28,456 | 21,893 |
| Accrued Expenses | 347,404 | 226,007 | 214,112 | 254,525 | 273,673 |
| TOTAL | $372,297 | $263,629 | $255,042 | $282,981 | $295,566 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,957 | 36,867 | 36,781 | 36,698 | 36,618 |
| Other Non-Current Liabilities | 19,491 | 19,141 | 262,713 | 260,844 | 260,789 |
| TOTAL | $56,448 | $56,008 | $299,494 | $297,542 | $297,407 |
| Total Liabilities | $428,745 | $319,637 | $554,536 | $580,523 | $592,973 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 120,871 | 116,227 | 115,933 | 115,897 | 115,213 |
| Common Shares | 12 | 12 | 12 | 12 | 12 |
| Retained earnings | -1,345,326 | -1,309,795 | -1,607,562 | -1,550,993 | -1,500,297 |
| Other shareholders' equity | -203 | -275 | -275 | -275 | -275 |
| TOTAL | $87,774 | $119,827 | $-183,470 | $-131,990 | $-87,973 |
| Total Liabilities And Equity | $516,519 | $439,464 | $371,066 | $448,533 | $505,000 |